Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,752 across all filing types
Latest filing 2026-05-27 Report Publication Anno…
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Earning Call Transcript
Report Publication Announcement Classification · 85% confidence The document is a brief notice to stock exchanges under SEBI LODR Reg. 30 that the transcript of the analysts/investor conference call on audited results has been placed on the company’s website. It does not contain the transcript itself or substantive financial data, but merely announces the publication of that report. This fits the definition of a Report Publication Announcement (RPA).
2026-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 92% confidence The document is a stock exchange filing notifying that the transcript of a conference call has been placed on the company’s website. It does not contain the actual transcript, but merely announces its publication in compliance with SEBI Listing Regulations. This matches the definition of a Report Publication Announcement (RPA), rather than a Call Transcript (CT) or another filing type.
2026-05-27 English
Annual Secretarial Compliance Report for 2025-26
Regulatory Filings Classification · 91% confidence The document is titled “Annual Secretarial Compliance Report for the year ended 31-Mar-26” and is issued under Regulation 24A of SEBI (LODR) Regulations. It is a compliance certificate by a practicing company secretary covering statutory and listing compliances, not a financial statement (10-K/IR) or an audit of financials, nor an announcement of a report’s publication. It constitutes a general regulatory filing/certificate under SEBI rules. Thus, it falls into the “Regulatory Filings” (RNS) category.
2026-05-23 English
Audio Recording of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2026
Regulatory Filings Classification · 90% confidence The document is a stock exchange disclosure letter informing that the audio recording of the analysts/investors conference call on audited financial results has been posted on the company website. It contains no financial data itself and is simply a regulatory announcement of where to access the call recording. It does not include the transcript or actual earnings figures, so it does not qualify as a Call Transcript (CT) or Earnings Release (ER). This is a general regulatory announcement and thus falls under the fallback category Regulatory Filings (RNS).
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a short letter sent to stock exchanges under SEBI Listing Regulations announcing that the audio recording of the conference call on the audited financial results has been placed on the company’s website with a link. It is not the transcript itself nor the actual financial results report, but a regulatory disclosure notice. This does not fit into specific report categories (10-K, IR, CT, etc.) and is a general regulatory announcement, so it falls under Regulatory Filings (RNS).
2026-05-22 English
Dividend Updates
Audit Report / Information Classification · 90% confidence The document is a statutory SEBI Listing Regulation disclosure of the audited financial results (standalone and consolidated) for the year and quarter ended March 31, 2026, and includes the full Independent Auditor’s Report. It is not merely a dividend notice, earnings highlights, or a proxy statement, nor does it represent the company’s full Annual Report (10-K). It contains the stand-alone audit report and audited financial statements, matching the “Audit Report / Information” category (AR). FY 2026
2026-05-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.